Cargando…
Immune suppression in chronic hepatitis B infection associated liver disease: A review
Hepatitis B virus (HBV) infection is one the leading risk factors for chronic hepatitis, liver fibrosis, cirrhosis and hepatocellular cancer (HCC), which are a major global health problem. A large number of clinical studies have shown that chronic HBV persistent infection causes the dysfunction of i...
Autores principales: | Li, Tian-Yang, Yang, Yang, Zhou, Guo, Tu, Zheng-Kun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6658392/ https://www.ncbi.nlm.nih.gov/pubmed/31367154 http://dx.doi.org/10.3748/wjg.v25.i27.3527 |
Ejemplares similares
-
Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection
por: Shao, Xue, et al.
Publicado: (2017) -
The Role of Immune Cells in Chronic HBV Infection
por: Li, Hai-Jun, et al.
Publicado: (2015) -
Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response
por: Shen, Yue, et al.
Publicado: (2022) -
B Cell-mediated Humoral Immunity in Chronic Hepatitis B Infection
por: Li, Yang, et al.
Publicado: (2021) -
Chronic hepatitis B infection and liver cancer
por: Wong, CH, et al.
Publicado: (2006)